Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
33.01
+0.49 (1.51%)
Mar 3, 2026, 4:00 PM EST - Market closed
Tyra Biosciences Employees
Tyra Biosciences had 60 employees as of December 31, 2024. The number of employees increased by 11 or 22.45% compared to the previous year.
Employees
60
Change (1Y)
11
Growth (1Y)
22.45%
Revenue / Employee
n/a
Profits / Employee
-$1,999,117
Market Cap
1.78B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 60 | 11 | 22.45% |
| Dec 31, 2023 | 49 | 11 | 28.95% |
| Dec 31, 2022 | 38 | 13 | 52.00% |
| Dec 31, 2021 | 25 | 12 | 92.31% |
| Jun 30, 2021 | 16 | - | - |
| Mar 31, 2021 | 13 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 1,372 |
| Agios Pharmaceuticals | 540 |
| Zymeworks | 263 |
| Relay Therapeutics | 188 |
| Innoviva | 127 |
| Kodiak Sciences | 123 |
| Definium Therapeutics | 74 |
| Enliven Therapeutics | 65 |
TYRA News
- 1 day ago - Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - PRNewsWire
- 8 days ago - Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium - PRNewsWire
- 12 days ago - Tyra Biosciences to Participate in Upcoming Investor Conferences - PRNewsWire
- 3 months ago - Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer - PRNewsWire
- 3 months ago - Tyra Biosciences Announces Participation at Upcoming Investor Events - PRNewsWire
- 4 months ago - Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights - PRNewsWire
- 6 months ago - Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia - PRNewsWire
- 7 months ago - Tyra Biosciences Reports Second Quarter 2025 Financial Results and Highlights - PRNewsWire